The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Benin's government said on Sunday its armed forces had foiled a coup attempt after a group of soldiers in the West African nation claimed on national television to have seized power. Israeli soldiers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback